| Hawk Resources Limited (HWK) ORDINARY FULLY PAID |
Materials |
$22 |
HWK July 2026 Investor Presentation
|
14 Jul 2026 10:03AM |
$0.025 |
$0.032 |
risen by
28%
|
|
| La Trobe Private Credit Fund (LF1) ORDINARY UNITS FULLY PAID |
Financials |
$262 |
Portfolio Update Webinar Presentation Deck
|
14 Jul 2026 10:02AM |
$1.900 |
$1.910 |
risen by
0.53%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$3,201 |
Pivotal Phase 3 Trial in CLBP Achieves 300 Treated Patients
|
14 Jul 2026 10:00AM |
$2.320 |
$2.465 |
risen by
6.25%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Mesoblast has achieved its target of 300 patients treated in the MSB-DR004 pivotal Phase 3 trial for chronic low back pain (CLBP) associated with degenerative disc disease.
- The trial aims to confirm durable pain reduction from a single intra-discal injection of rexlemestrocel-L, seen in the earlier MSB-DR003 trial.
- The primary endpoint is to show significant pain reduction at 12 months between rexlemestrocel-L and sham controls.
- Secondary endpoints include improvements in function, quality of life, and cessation of pain medication, including opioids.
- Rexlemestrocel-L has received RMAT designation from the FDA for CLBP treatment, providing eligibility for priority review post-BLA filing.
- Top-line results of the trial are expected in mid-2027.
- The trial is actively enrolling patients across multiple sites in the U.S.
- Mesoblast is a leader in developing cellular medicines for inflammatory diseases and has a strong intellectual property portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vintage Energy Ltd (VEN) ORDINARY FULLY PAID |
Energy |
$5 |
Shortfall Offer closure this week
|
14 Jul 2026 9:59AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$370 |
Consolidation/Split - ID8
|
14 Jul 2026 9:58AM |
$0.003 |
$0.400 |
risen by
13,233.33%
|
|
| Synertec Corporation Limited (SOP) ORDINARY FULLY PAID |
Industrials |
$27 |
Santos orders more Powerhouse units
|
14 Jul 2026 9:57AM |
$0.036 |
$0.052 |
risen by
44.44%
|
|
SOP - Price-sensitive ASX Announcement
Full Release
Key Points
- Synertec signed contracts for two more Powerhouse systems with Santos
- Total Powerhouse systems contracted to Santos is now six
- Operates under a BOOM model providing Power-as-a-Service
- Powerhouse systems use smart Predictive Intelligence technology
- Unit #6 awaits final investment sanction for FY27 execution
- Synertec enhances energy efficiency, reducing operational costs
- Scalable deployment through a global supply chain
- Synertec positioned for growth in renewable energy markets
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TMK Energy Limited (TMK) ORDINARY FULLY PAID |
Energy |
$36 |
Building Mongolia's Gas and Energy Export Future
|
14 Jul 2026 9:56AM |
$0.140 |
$0.135 |
fallen by
3.57%
|
|
| Aroa Biosurgery Limited (ARX) ORDINARY FULLY PAID |
Health Care |
$201 |
Symphony - Outpatient Reimbursement Update
|
14 Jul 2026 9:56AM |
$0.585 |
$0.580 |
fallen by
0.85%
|
|
| LendLease Group (LLC) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$2,017 |
Notification of cessation of securities - LLC
|
14 Jul 2026 9:56AM |
$2.990 |
$2.920 |
fallen by
2.34%
|
|
| LendLease Group (LLC) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$2,017 |
Notification of cessation of securities - LLC
|
14 Jul 2026 9:55AM |
$2.990 |
$2.920 |
fallen by
2.34%
|
|
| LendLease Group (LLC) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$2,017 |
Notification of cessation of securities - LLC
|
14 Jul 2026 9:54AM |
$2.990 |
$2.920 |
fallen by
2.34%
|
|
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$81 |
Net Tangible Asset Backing June 2026
|
14 Jul 2026 9:52AM |
$1.400 |
$1.370 |
fallen by
2.14%
|
|
| Genesis Minerals Limited (GMD) ORDINARY FULLY PAID |
Materials |
$8,688 |
Proposed issue of securities - GMD
|
14 Jul 2026 9:52AM |
$5.880 |
$7.405 |
risen by
25.94%
|
|
| Solis Minerals Ltd (SLM) ORDINARY FULLY PAID |
Materials |
$24 |
Drilling Commenced At Mandacaru Lithium Project, Brazil
|
14 Jul 2026 9:51AM |
$0.094 |
$0.072 |
fallen by
23.40%
|
|
SLM - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling has commenced at Mandacaru Lithium Project.
- The program consists of 10 drill holes over a 2,000-meter span.
- Aim is to explore a lithium-caesium-tantalum pegmatite system.
- Project located in Minas Gerais, Brazil, within Araçuaí Lithium Valley.
- Drilling designed to test pegmatite continuity and spodumene potential.
- Multi-element geochemistry supports the technical basis for drilling.
- The project is in a world-class lithium province.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Western Yilgarn NL (WYX) ORDINARY FULLY PAID |
Materials |
$6 |
Gold Exploration at Ida Holmes Junction Project
|
14 Jul 2026 9:50AM |
$0.032 |
$0.036 |
risen by
12.50%
|
|
WYX - Price-sensitive ASX Announcement
Full Release
Key Points
- First-ever gold evaluation at Ida Holmes Junction Project.
- Identification of a significant hidden greenstone belt.
- Presence of major structural features such as the Ida Fault and Waroonga Shear Zone.
- Five high-priority gold exploration targets identified.
- Focus on both bedrock and palaeochannel gold systems.
- Increased gold potential due to hydrothermal markers like quartz veins and cobalt-rich asbolane.
- Upcoming steps include regulatory approval and drilling initiation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$22 |
Cleansing Notice
|
14 Jul 2026 9:49AM |
$0.078 |
$0.071 |
fallen by
8.97%
|
|
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$26 |
EXO-OC Study Outcome Investor Webinar Presentation
|
14 Jul 2026 9:49AM |
$0.220 |
$0.185 |
fallen by
15.91%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ Ltd presented an investor webinar on the EXO-OC test.
- The EXO-OC test uses exosomal biomarkers and CA125 integrated with AI/ML algorithms for early detection of ovarian cancer.
- The study used a retrospective case-control design with biobanked plasma samples.
- The test achieved 100% sensitivity for Stage I/II and >99.6% specificity overall.
- The test is intended for both high-risk women as a Laboratory Developed Test (LDT) and average-risk postmenopausal women as an In Vitro Diagnostic (IVD).
- Dual commercialisation paths are planned for the EXO-OC test as both LDT and IVD.
- Regulatory approvals are being sought in multiple regions, including the US FDA and Australian ARTG.
- The EXO-OC test seeks to address the unmet need for ovarian cancer screening.
- INOVIQ plans to continue validating and commercialising the EXO-OC test.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Argo Global Listed Infrastructure Limited (ALI) ORDINARY FULLY PAID |
Financials |
$494 |
Weekly NTA estimate - Fri 10.7.26
|
14 Jul 2026 9:48AM |
$2.560 |
$2.620 |
risen by
2.34%
|
|
| Tamawood Limited (TWD) ORDINARY FULLY PAID |
Consumer Discretionary |
$104 |
FY26 Unaudited Profit Before Tax Up 40% on Prior Year
|
14 Jul 2026 9:48AM |
$2.450 |
$2.630 |
risen by
7.35%
|
|
TWD - Price-sensitive ASX Announcement
Full Release
Key Points
- FY26 profit before tax expected to be $11.679 million.
- This is a 40% increase from FY25 profit before tax of $8.299 million.
- Company remains debt-free with $8.346 million cash on hand as of 30 June 2026.
- Profit margins were partially impacted by higher construction input costs.
- No significant increase in contract cancellations due to bank valuations.
- Financial information is based on unaudited management accounts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$651 |
FY26 Production Results
|
14 Jul 2026 9:47AM |
$0.375 |
$0.435 |
risen by
16%
|
|
AIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Aeris Resources Limited (ASX: AIS) reported FY26 production results.
- Group copper equivalent production was 42.1kt, within guidance.
- Gold production was 49koz, also aligning with guidance.
- Tritton Copper Operations increased copper production by 19% year-over-year to 23kt, though this was 4% below guidance.
- The company ended FY26 with a strong cash and receivables position of $202.3 million.
- Unhedged for FY27 following delivery into all gold hedges by the end of Q4 FY26.
- Guidance for FY27 expected to be released in the coming weeks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Future Generation Australia Limited (FGX) ORDINARY FULLY PAID |
Financials |
$566 |
June 2026 Investment Update
|
14 Jul 2026 9:46AM |
$1.390 |
$1.375 |
fallen by
1.08%
|
|
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$22 |
Application for quotation of securities - GMN
|
14 Jul 2026 9:46AM |
$0.078 |
$0.071 |
fallen by
8.97%
|
|
| PhosCo Ltd (PHO) ORDINARY FULLY PAID |
Materials |
$76 |
PhosCo Appoints Project Director
|
14 Jul 2026 9:46AM |
$0.140 |
$0.140 |
fallen by
0%
|
|
| Mount Ridley Mines Limited (MRD) ORDINARY FULLY PAID |
Materials |
$40 |
Block 2 Re-Assays Further Extend Scandium Footprint
|
14 Jul 2026 9:45AM |
$0.023 |
$0.030 |
risen by
30.43%
|
|
MRD - Price-sensitive ASX Announcement
Full Release
Key Points
- Phase 1 Scandium Re-Assay Program confirms high-grade scandium mineralisation across Block 2.
- Significant scandium intercepts include 19m at 127.68 ppm Sc2O3.
- Scandium mineralisation extends beyond the current MRE boundaries with potential for further resource growth.
- The Grass Patch Complex hosts a large-scale critical minerals system.
- Phase 2 of the Re-Assay Program set to commence with collection of historical pulps.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stelar Metals Limited (SLB) ORDINARY FULLY PAID |
Materials |
$18 |
Initial Director's Interest Notice
|
14 Jul 2026 9:44AM |
$0.145 |
$0.220 |
risen by
51.72%
|
|